Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients-Reference-Cited by-同舟云学术

Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients

Published:2014-01-29 Issue:3 Volume:59 Page:1052-1059
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Buck Martina¹²³,Garcia-Tsao Guadalupe⁴⁵,Groszmann Roberto J.⁴⁵,Stalling Caitlin¹²,Grace Norman D.⁶⁷,Burroughs Andrew K.⁸,Patch David⁸,Matloff Daniel S.⁷,Clopton Paul¹,Chojkier Mario¹²³⁹

Affiliation:

1. Veterans Affairs San Diego Healthcare System; San Diego CA

2. Department of Medicine; University of California, San Diego; La Jolla CA

3. Biomedical Sciences Program; University of California, San Diego; La Jolla CA

4. Veterans Affairs Connecticut Healthcare System; West Haven CT

5. Yale University School of Medicine; New Haven CT

6. Brigham and Women's Hospital; Boston MA

7. Faulkner Hospital; Jamaica Plain MA

8. Royal Free Hospital and School of Medicine; London UK

9. Clinical Translational Research Institute; University of California, San Diego; La Jolla CA

Publisher

Wiley

Subject

Hepatology

Reference47 articles.

1. Portal hypertension and gastrointestinal bleeding;Bosch;Semin Liver Dis,2008

2. Report 04-5491. Executive Summary. Action Plan for Liver Disease Research 2004 1 6

3. Hemodynamic events in a prospective randomized trial of propranolol vs placebo in the prevention of the first variceal hemorrhage;Groszmann;Gastroenterology,1990

4. Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?;Burroughs;Gut,2002

5. Patients with clinically significant portal hypertension caused by hepatitis C virus cirrhosis respond poorly to antiviral therapy;Grace;Clin Gastroenterol Hepatol,2011

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomics reveals altered metabolites in cirrhotic patients with severe portal hypertension in Tibetan population;Frontiers in Medicine;2024-06-28

2. Serum proteomic profiling of patients with compensated advanced chronic liver disease with and without clinically significant portal hypertension;PLOS ONE;2024-04-11

3. Selection of patients with portal hypertension and cirrhosis who will benefit from beta-blockers: Still a current challenge;Journal of Hepatology;2024-01

4. Inflammation and autonomic balance in cirrhosis: Association between sympathetic nervous system and osteopontin, interleukin‐22, interleukin‐6 and interleukin‐1Ra concentrations according to portal hypertension and disease severity;Clinical and Translational Discovery;2023-11-07

5. Mechanisms of immunity in acutely decompensated cirrhosis and acute‐on‐chronic liver failure;Liver International;2023-06-27